Current Trends and Future Growth of Cardiac Rhythm Management (CRM) Devices Market

1. Current Trends and Future Growth of Cardiac Rhythm Management (CRM) Devices Market The global Cardiac Rhythm Management (CRM) Devices Market is estimated to reach USD 33.0 billion by 2026 from USD 17.2 billion in 2017. The market is anticipated to grow at a CAGR of 7.6% during the forecast period. High cholesterol level, high alcohol consumption, smoking and obesity causes heart diseases. Due to these reasons, approximately 30% of total deaths are caused by cardiovascular diseases across the world. Cardiac rhythm management is a procedure of monitoring the heart function through a device. This device is used to deliver therapeutic solutions to people suffering from cardiac disorders such as cardiac arrests, heart failure, or cardiac arrhythmias. Cardiac ailments are the primary reasons causing irregular heartbeat. Request for Sample of This Research Report @https://bit.ly/2CSb9hp Increasing patient awareness is considered to be one of the reasons generating lucrative market opportunity for the global Cardiac Rhythm Management (CRM) Devices market. The influence of this factor has affected the market growth significantly in emerging countries, as the usage and the adoption rate for these devices is very low in emerging regions. Currently, there are number of implantable-assisted and novel products available however, the patients and surgeons

2. present in developing economies are unaware about the advancement of CRM devices, thereby restricting the market growth. In addition, high prevalence of cardiovascular diseases, technological advancements, rising government initiatives and increasing rise in life expectancy are other factors anticipated to boost the cardiac rhythm management (CRM) devices market. The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global Cardiac Rhythm Management (CRM) Devices market, 2017- 2026. This report also comprises a detailed geographic analysis of the market across North America, Europe, APAC, Latin America, and MEA regions. North America is further segmented into U.S., Canada, and Mexico. European regional analysis section covers Germany, UK, Italy, and France. While the Asia Pacific region is bifurcated into China, India, and Japan. In 2017, North America Cardiac Rhythm Management (CRM) Devices Market was estimated to dominate the market growth due to developed healthcare infrastructure, favourable reimbursement schemes, higher healthcare expenditure, and increasing awareness among the population. Competitive Landscape and Key Vendors Some of the leading companies profiled in the Cardiac Rhythm Management (CRM) Devices Market report include Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric Company (GE), Hill- Rom Holdings, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, SCHILLER AG, and Abbott Laboratories. Key Segments Product • Pacemakers ▪ External Pacemakers ▪ Implantable pacemakers • Cardiac Resynchronization Therapy (CRT) ▪ CRT-Defibrillators (CRT-D) ▪ CRT-Pacemakers (CRT-P) • Defibrillators ▪ Implantable Cardioverter Defibrillators (ICDs)

3. o o Transvenous ICD (T-ICD) Subcutaneous ICD (S-ICD) ▪ External Defibrillator (ED) o o o Manual ED Automated ED (AED) Wearable Cardioverter Defibrillator Region •North America oU.S. oCanada oMexico •Europe oGermany oUK oFrance oItaly oRest of Europe •Asia-Pacific oChina oIndia oJapan oRest of Asia-Pacific •Latin America oBrazil oRest of Latin America •Middle East and Africa Request Discount on this Report before Buying @ https://www.polarismarketresearch.com/industry-analysis/cardiac-rhythm- management-devices-market/inquire-before-buying Contact Us: Polaris Market Research 30 Wall Street

4. 8th Floor, New York City, NY 10005, United States +1-646-568-9980 Email ID: sales@polarismarketresearch.com Follow us: LinkedIn | Twitter | Facebook | Google+